Работы, цитирующие эту работу

Работ: 6

Работа: Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

1. COVID-19 Response in Uzbekistan: From RT-PCR Test System to the Clinical Trial of Subunit Vaccine

   Shahlo Тurdikulova, Dilbar Dalimova, А. А. Абдуллаев +7

   ГлаваSARS-CoV-2 and COVID-19 ResearchIntechOpen eBooks2022Цитирований: 2

   ABIABI:AkademIndex/openalex/2026.other.451742

2. Seroepidemiological study of factors affecting anti-spike IgG antibody titers after a two-dose mRNA COVID-19 vaccination in 3744 healthy Japanese volunteers

   Aya Sugiyama, Akemi Kurisu, Shintaro Nagashima +13

   СтатьяSARS-CoV-2 and COVID-19 ResearchScientific Reports2022Цитирований: 1

   ABIABI:AkademIndex/openalex/2022.article.000606

3. COVID-19 Vaccines - Current State and Perspectives

   Ibrokhim Y. Abdurakhmonov

   КнигаSARS-CoV-2 and COVID-19 ResearchIntechOpen eBooks2022Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.451741

4. Neurological complications after covid-19 vaccination

   K. Khalimova, Nilufar Rashidova, Javlon Salimjonov

   СтатьяSARS-CoV-2 and COVID-19 ResearchS S Korsakov Journal of Neurology and Psychiatry2023Цитирований: 0

   ABIABI:AkademIndex/openalex/2023.article.012313

5. Neurological Complications after COVID-19 Vaccination

   K. Khalimova, Nilufar Rashidova, Javlon Salimjonov

   СтатьяPeripheral Neuropathies and DisordersNeuroscience and Behavioral Physiology2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.article.006492

6. Development, Pre-Clinical Safety, and Immune Profile of RENOVAC—A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine

   Muzaffar Muminov, Nargiza A. Tsiferova, Egor Pshenichnov +15

   СтатьяSARS-CoV-2 and COVID-19 ResearchVaccines2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.article.009664